Picture of Cavendish logo

CAV Cavendish News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapContrarian

Holding(s) in Company

RNS Number : 5899U

Cavendish PLC

26 February 2026

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BGKPX309

Issuer Name

CAVENDISH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Singer Capital Markets Securities Limited

City of registered office (if applicable)

 

Country of registered office (if applicable)

GB

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

24-Feb-2026

6. Date on which Issuer notified

24-Feb-2026

7. Total positions of person(s) subject to the notification obligation

.% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached3.4700000.0000003.47000013440000
Position of previous notification (if applicable)
  8. Notified details of the resulting situation on the date on which the threshold was crossed or reached   8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GB00BGKPX309134400003.470000
Sub Total 8.A134400003.470000%
  8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))  
Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights
Sub Total 8.B1
  8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))  
Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Sub Total 8.B2
  9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Singer Capital Markets LimitedSinger Capital Markets Securities Limited3.4700000.0000003.470000%
  10. In case of proxy voting   Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held   11. Additional Information   12. Date of Completion 24-Feb-2026   13. Place Of Completion London, England   This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     HOLFLFVEFRIRFIR

Recent news on Cavendish

See all news